Myriad Reports 37 Percent Revenue Growth for Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported on Tuesday a 37 percent increase in fiscal year 2014 second quarter revenues compared to the year-ago period.

For the three months ended Dec. 31, 2013, the company brought in total revenues of $204.1 million, up from $149.1 million in the second quarter of 2013, and above analysts' consensus estimate of $176 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.